Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna (with colleagues at University of California) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Novartis and Regeneron.

Property Value
dbo:abstract
  • Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna (with colleagues at University of California) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Novartis and Regeneron. (en)
dbo:industry
dbo:type
dbo:wikiPageEditLink
dbo:wikiPageExtracted
  • 2020-02-11 00:58:28Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 55924239 (xsd:integer)
dbo:wikiPageLength
  • 11479 (xsd:integer)
dbo:wikiPageModified
  • 2020-02-11 00:58:24Z (xsd:date)
dbo:wikiPageOutDegree
  • 41 (xsd:integer)
dbo:wikiPageRevisionID
  • 940181581 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna (with colleagues at University of California) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Novartis and Regeneron. (en)
rdfs:label
  • Intellia Therapeutics (en)
foaf:isPrimaryTopicOf
foaf:name
  • Intellia Therapeutics (en)
owl:sameAs
is foaf:primaryTopic of